Literature DB >> 3772341

Persistence of free HBV DNA in body secretions and liver despite loss of serum HBV DNA after interferon-induced seroconversion.

E A Fagan, G J Alexander, F Davison, R Williams.   

Abstract

Following interferon therapy, a chronic hepatitis B (HBV) carrier lost all serum markers of active viral replication and became anti-HBe positive but remained positive for free and replicative HBV-DNA in semen, saliva, urine, and liver four months later. At 12 months, when he also developed anti-HBs, urine and saliva analysed for free HBV-DNA were positive. Despite histological remission and loss of HBV-DNA from serum, the potential for transmission of HBV and reactivation of disease remain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772341     DOI: 10.1002/jmv.1890200210

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Review.

Authors:  Usman Khokhar; Debra Stevens; Linda K Shipton; Daryl T-Y Lau
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

2.  Hepatitis B: the immaculate infection.

Authors:  Annmarie Huysman; Mitul Patel; Douglas T Dieterich
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

Review 3.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

4.  Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.

Authors:  Y S White; P J Johnson; F Davison; R Williams
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

5.  Viral infections and implications for male reproductive health.

Authors:  Thiago A Teixeira; Yasmin C Oliveira; Felipe S Bernardes; Esper G Kallas; Amaro N Duarte-Neto; Sandro C Esteves; Joël R Drevet; Jorge Hallak
Journal:  Asian J Androl       Date:  2021 Jul-Aug       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.